Balancing safety, efficacy and cost: Improving rotavirus vaccine adoption in low- and middle-income countries.

Reduced efficacy alone, however, should not deter policy makers in LMICs from accelerating their adoption, as the potential public health benefits – lives saved and infections averted – are still highly significant.

also in 132,142 other papers